Skip to main content
Year archive

Sopharma AD — 2024 filings

All 38 regulatory filings released by Sopharma AD (SFA) in 2024, sourced directly from the official regulator.

38 Filings
2024 Period
2024 filings (38)
Filing Released Lang
Individual financial report according to IFRS as at 31 March 2024
Annual / Quarterly Financial Statement
2024-04-30 Polish
Publication of Annual consolidated audited financial report of "Sopharma" AD for 2023 in ESF format
Annual Report (ESEF) FY 2023
2024-04-25 Polish
610654-SFA_Annual_cons_financial_statements_2023_EN.pdf
Audit Report / Information FY 2023
2024-04-24 English
610652-097900BGGW0000048796-20231231-EN-CON.zip
Annual Report (ESEF) FY 2023
2024-04-24 Bulgarian
610653-SFA_2023_cons_Financial_Report_according_to_BFSC_standards_EN.xls
Annual / Quarterly Financial Statement
2024-04-24 Bulgarian
610651-SFA_Annual_cons_financial_statements_2023_BG.pdf
Report Publication Announcement FY 2023
2024-04-24 Bulgarian
610650-SFA_2023_cons_Financial_Report_according_to_BFSC_standards_BG.xlsx
Annual / Quarterly Financial Statement
2024-04-24 Bulgarian
097900BGGW0000048796-20231231-BG-CON.zip
Annual Report (ESEF) FY 2023
2024-04-24 Bulgarian
Sales revenues of Sopharma AD for March 2024
Earnings Release Q1 2024
2024-04-22 English
Presentation of the Annual Audited Individual Financial Statements of "Sopharma" AD as at 31 December 2022
Annual / Quarterly Financial Statement
2024-04-02 Polish
608813-SFA_2023_ind_Financial_Report_according_to_BFSC_standards_EN.xls
Annual / Quarterly Financial Statement
2024-03-31 Bulgarian
608810-SFA_Annual_ind_financial_statements_2023_BG.pdf
Report Publication Announcement
2024-03-31 Bulgarian
608809-SFA_2023_ind_Financial_Report_according_to_BFSC_standards_BG.xlsx
Annual / Quarterly Financial Statement
2024-03-31 Bulgarian
608814-SFA_Annual_ind_financial_statements_2023_EN.pdf
Report Publication Announcement
2024-03-31 English
608812-097900BGGW0000048796-20231231-EN-SEP.xhtml
Annual Report FY 2023
2024-03-31 English
608811-SFA_Scorecard_according_to_NCGS_2023_BG.xls
Governance Information
2024-03-31 Bulgarian
097900BGGW0000048796-20231231-BG-SEP.xhtml
Annual Report FY 2023
2024-03-31 Bulgarian
Sales revenues for February 2024
Regulatory Filings
2024-03-20 English
Incoming transfer from capital increase subject to exercise of warrants from issue BG9200001212
Director's Dealing
2024-03-12 English
Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 08 March 2024 on the acquisition of shares from a capital increase
Major Shareholding Notification
2024-03-11 Polish
Consolidated financial report as of 31 December 2023
Annual / Quarterly Financial Statement
2024-02-29 Polish
Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212
Share Issue/Capital Change
2024-02-27 English
Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 19 February 2024 on the acquisition of shares from a temporary issue/exercise of warrants
Director's Dealing
2024-02-22 English
Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 19 February 2024 on the exercise of warrants in a capital increase under the condition
Director's Dealing
2024-02-22 English
zal01_Donev_Sopharma_temp_issue_EN_19022024.pdf
Director's Dealing
2024-02-20 English
zal01_Donev_Sopharma_exercise_EN_19022024.pdf
Director's Dealing
2024-02-20 English
zal01_Donev_Sopharma_EN_19022024.pdf
Director's Dealing
2024-02-20 English
zal01_Donev_Sopharma_EN_19022024.pdf
Director's Dealing
2024-02-20 English
Notification for Sales revenues for January 2024
Earnings Release Q1 2024
2024-02-19 English
Technical error in the Notification under Art. 89t of the Law on Public Offering of Securities published on 26.01.2024
Regulatory Filings
2024-01-31 English
Individual financial report according to IFRS as of 31 December 2023
Annual / Quarterly Financial Statement
2024-01-30 Polish
Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOFARMA" AD, UIC 831902088, with registered office and management address in the city of Sofia, Nadezhda dis...
Share Issue/Capital Change
2024-01-26 English
Sopharma AD-Sofia presented inutes of the General Meeting of Warrant Holders held on 26-01-2024 11:00 a.m
Pre-Annual General Meeting Information
2024-01-26 Polish
Sales revenues for December 2023
Earnings Release FY 2023
2024-01-22 English
Presentation of materials and Invitation for General Meeting of Warrant holders of Sopharma AD
Pre-Annual General Meeting Information
2024-01-19 Polish
Merger of the subsidiary "Veta pharma" AD into "Sopharma" AD
M&A Activity
2024-01-15 English
"Sopharma" AD starts the payment of the dividend for the 6 months of 2023 on January 22, 2024
Notice of Dividend Amount
2024-01-10 English
Notification from Ognian Donev under Art. 19 of Regulation (EU) ą 596/2014 of the European Parliament and of the Council of April 16, 2014 from 22 December 2023
Director's Dealing
2024-01-02 English